Table 2. Bivariate and multivariate association of impact factors with sexual function.

Predictor	Mo-Se ED Vs. Non-ED				Asexuality status Vs. Non-ED
			Odds Ratio (95% CI)
	Unadjusted	p	Adjusted	p	Unadjusted	p	Adjusted	p
Age
40–51	1.00		1.00		1.00		1.00
52–59	2.61(1.16–5.87)	0.02	2.94 (1.26–6.83)	0.01	3.05 (1.71–5.45)	<0.001	2.99 (1.66–5.40)	<0.001
60–64	4.41 (1.97–9.88)	<0.001	3.71 (1.57–8.77)	0.003	8.56 (4.81–15.21)	<0.001	8.26(4.54–15.05)	<0.001
65–80	8.01 (3.62–17.71)	<0.001	7.19(3.03–17.10)	<0.001	18.49(10.34–33.05)	<0.001	17.69(9.59–32.61)	<0.001
BMI ≥25	1.57 (0.99–2.51)	0.06	1.55(0.89–2.67)	0.12	1.06 (075–1.49)	0.75	1.04 (0.69–1.57)	0.86
WC ≥90	1.34 (0.81–2.21)	0.26	1.49 (0.82–2.73)	0.19	0.75 (0.51–1.11)	0.15	0.81 (0.51–1.29)	0.38
Lifestyle
Exercise	0.69(0.44–1.09)	0.11	0.92 (0.55–1.55)	0.76	0.84 (0.60–1.17)	0.29	0.93 (0.63–1.36)	0.71
Alcohol	0.84(0.53–1.34)	0.46	0.93 (0.55–1.58)	0.79	1.14 (0.81–1.59)	0.45	1.22 (0.83–1.80)	0.32
Tea	0.77 (0.48–1.23)	0.27	0.69 (0.41–1.16)	0.16	1.21 (0.87–1.69)	0.25	0.89 (0.61–1.31)	0.57
Smoking	1.50 (0.95–2.36)	0.08	1.29 (0.76–2.18)	0.35	1.32 (0.95–1.82)	0.09	0.95 (0.65–1.39)	0.79
Chronic disease
Diabetes	2.36 (1.16–4.80)	0.02	1.76 (0.79–3.93)	0.17	2.40 (1.36–4.25)	0.003	1.79 (0.95–3.36)	0.07
Hypertension	1.72 (1.07–2.79)	0.03	1.11 (0.64–1.92)	0.71	1.78(1.25–2.55)	0.002	1.09 (0.73–1.66)	0.65
Dyslipidemia	1.57 (0.75–3.31)	0.23	0.79 (0.34–1.85)	0.59	0.99 (0.55–1.80)	0.99	0.65 (0.33–1.28)	0.22
BPH	3.58 (1.55–8.25)	0.03	2.08 (0.81–5.29)	0.13	1.75 (0.84–3.66)	0.14	1.15 (0.51–2.61)	0.73
PLS	5.88(1.20–28.79)	0.03	4.32 (0.75–25.04)	0.10	4.11 (0.96–17.58)	0.06	3.53 (0.71–17.43)	0.12

Abbreviations: ED, erectile dysfunction; CI, confidence interval; BMI, body mass index; WC, waist circumference; BPH, benign prostatic hyperplasia; PLS, prostatatis–like symptom, Vs., versus.

Multivariate regression: All variables listed in the table have been included in the multivariate logistic regression model simultaneously.